Chapter 7.Hypnotics
Sections
Excerpt
Insomnia is generally defined as a difficulty initiating or maintaining sleep or a poor quality of sleep. Insomnia may be primary or secondary to other conditions such as depression, anxiety, mania, or substance abuse. Primary insomnia appears to be uncommon relative to secondary insomnia. Various population surveys have found self-reported rates of symptoms of insomnia in about a third of adults. About 10% of the U.S. population report having experienced symptoms of chronic insomnia that may have lasted for many years. However a smaller percentage of patients have insomnia with significant daytime impairment. According to the “NIH State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults Statement” (2005), perhaps 10% of the population has clinically significant insomnia if the criterion of daytime impairment is included in the criteria. According to a 2014 survey by the National Sleep Foundation, about 17% of the population use a hypnotic at least once a week and 10% of the population use a some kind of sleeping aid on a daily basis (National Sleep Foundation 2014). Women and older adults appear to be the demographic groups at greatest risk for significant insomnia, but of course transient insomnia can affect anyone.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).